Meeting abstracts Glioblastoma (GBM) remains incurable with current standard-of-care therapies. Adoptive T cell transfer holds the promise to improve outcomes for GBM patients. We report on the results of the Phase I clinical study, [NCT01109095][1], administering autologous CMV.pp65 T cells
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2015) studied this question.